 Effect dipyridamole Persantin blood flow patency aortocoronary vein bypass grafts effect dipyridamole patients undergoing coronary bypass surgery dipyridamole mg days mg/kg body i.v mg year placebo study patients dipyridamole placebo Cardiovascular and/or cerebrovascular events need anticoagulant treatment reasons withdrawal dipyridamole placebo group Logistic regression analysis risk factors graft patency significant relation coronary blood flow positive trend treatment Vein graft blood flow bypass surgery patients dipyridamole group occlusion rate vessels peroperative blood flow ml/min vein-marginal vein-dexter vein-diagonal Dipyridamole coronary blood flow graft patency coronary bypass surgery